Literature DB >> 3743622

Trimethoprim: prediction of serum concentrations from saliva measurements.

I D Watson, M J Stewart.   

Abstract

Saliva has been used in the past as a non-invasive predictor of serum drug concentration. Prediction may be made from a regression line of saliva versus serum concentration or from an equation proposed by Matin et al. (1974); such predictions have been examined for trimethoprim, a drug that has a pKa of 7.3, the degree of ionisation influencing its partition between saliva and serum. A relationship was found between serum and saliva trimethoprim concentrations. Salivary trimethoprim concentrations were marginally related to salivary flow rate, but not salivary pH. The precision and bias of prediction from linear regression and the equation of Matin et al. (1974) was considered; the equation did not describe the relationship between serum and saliva trimethoprim concentrations and we conclude that its use is inappropriate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743622     DOI: 10.1007/bf00607960

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  pH-dependent secretion of procainamide into saliva.

Authors:  J R Koup; W J Jusko; A L Goldfarb
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  Drug concentration in saliva.

Authors:  J C Mucklow; M R Bending; G C Kahn; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1978-11       Impact factor: 6.875

3.  Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors:  S B Matin; S H Wan; J H Karam
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

4.  Assay and pharmacokinetics of trimethoprim in man and animals.

Authors:  D E Schwartz; W H Ziegler
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

5.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

6.  Proposed model for screening antimicrobial agents for potential use in eliminating meningococci from the nasopharynx of healthy carriers.

Authors:  L F Devine; R C Knowles; W E Pierce; R O Peckinpaugh; C R Hagerman; R I Lytle
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

7.  Plasma protein binding of sulphadiazine, sulphamethoxazole and trimethoprim determined by ultrafiltration.

Authors:  A Wijkström; D Westerlund
Journal:  J Pharm Biomed Anal       Date:  1983       Impact factor: 3.935

8.  Saliva concentrations of lidocaine and its metabolites in man.

Authors:  A Barchowsky; W W Stargel; D G Shand; P A Routledge
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

9.  Assay for trimethoprim in serum and urine by means of ion-pair chromatography.

Authors:  I D Watson; A Shenkin; S J McIntosh; H N Cohen
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

10.  Pharmacokinetics of two dosage levels of trimethoprim to 'steady-state' in normal volunteers.

Authors:  I D Watson; M J Stewart; A Wiles; S J McIntosh
Journal:  J Int Med Res       Date:  1983       Impact factor: 1.671

View more
  2 in total

1.  Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors.

Authors:  Clifford M Csizmar; Jacob R Petersburg; Alex Hendricks; Lawrence A Stern; Benjamin J Hackel; Carston R Wagner
Journal:  Bioconjug Chem       Date:  2018-03-23       Impact factor: 4.774

Review 2.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.